Skip to main content

Xenon Pharmaceuticals Inc.

XENE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001582313

In the last 90 days, Xenon Pharmaceuticals Inc. insiders filed 2 open-market purchases and 2 sales; 315 institutions reported holding it in 13F filings for Q2 2026, worth $6.10B in total; Duquesne Family Office is the only superinvestor holding it.

Q2 2021 vs. Q1 2021

How the institutions holding Xenon Pharmaceuticals Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of XENE: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders91103+12
Shares33.0M33.6M+608.3K (+1.8%)
Value$590.0M$620.0M+$30.0M (+5.1%)

New holders (16)

Institutions that held Xenon Pharmaceuticals Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to XENE in Q2 2021
InstitutionSharesValue% of portfolio
Boxer Capital, LLC857,000$16.0M0.56%
Candriam Luxembourg S.C.A.715,722$13.3M0.09%
Marshall Wace North America L.P.411,259$7.66M0.03%
Nan Fung Group Holdings Ltd197,880$3.69M1.14%
Altium Capital Management LP155,000$2.89M0.67%
HighVista Strategies LLC40,959$763.0K0.54%
M&G Investment Management Ltd34,103$648.0K0.00%
International Biotechnology Trust PLC25,500$474.0K0.13%
Alliancebernstein L.P.19,908$371.0K0.00%
Dimensional Fund Advisors LP15,010$279.0K0.00%
Vident Investment Advisory, LLC11,731$218.0K0.01%
Marshall Wace, LLP10,453$195.0K0.00%
Group One Trading, L.P.890$17.0K0.00%
Cutler Group LP893$16.0K0.00%
State of Wyoming64$1.00K0.00%
Sphera Funds Management Ltd.276,130––

Sold out (4)

Institutions that held Xenon Pharmaceuticals Inc. at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of XENE in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
California Public Employees Retirement System69,800$1.25M
Engineers Gate Manager LP11,330$203.0K
Monashee Investment Management LLC10,365$186.0K
Athanor Capital, LP10,077$180.0K